Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

Publisher： Karger

E-ISSN： 1421-9662|119|3|133-141

ISSN： 0001-5792

Source： Acta Haematologica, Vol.119, Iss.3, 2008-04, pp. : 133-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 113-118

Karger

Access to resources Recommend Favorite

A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer

By Ring Alistair E.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 2, 2008-01 ,pp. : 105-113

Adis International

Access to resources Recommend Favorite

Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change

By Matza Louis S.   Yurgin Nicole   Boye Kristina S.   Malley Karen   Shorr Jodi M.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2051-2062

Informa Healthcare

Access to resources Recommend Favorite

Patients with Advanced Disease: The Value of Patient Reported Outcomes

By  

Oncology Research and Treatment, Vol. 37, Iss. 1-2, 2014-01 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

Factors affecting patient‐reported outcomes after red blood cell transfusion in medical patients

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 158-167

John Wiley & Sons Inc

Access to resources Recommend Favorite